Mylan N.V., formerly Mylan Inc., is a global pharmaceutical company, which develops, licenses, manufactures, markets and distributes generic, branded generic and specialty pharmaceuticals. Mylan operates in two segments: Generics and Specialty. Mylan applies one global quality standard across our facilities, and across our product line regardless of market. At Mylan, whether it’s a medication for millions or for a handful of people our priorities are to meet or exceed industry standards.

Company Growth (employees)
Type
Public
HQ
Hatfield, GB
Founded
1961
Size (employees)
35,000 (est)
Website
mylan.com
Mylan was founded in 1961 and is headquartered in Hatfield, GB

Key People at Mylan

Heather Bresch

Heather Bresch

Chief Executive Officer

Mylan Office Locations

Mylan has an office in Hatfield
Hatfield, GB (HQ)
Mosquito Way

Mylan Metrics

Mylan Financial Metrics

Revenue (2014)

$7.6 b

Revenue growth (2013-14), %

12%

Gross profit

$3.5 b

Gross profit margin (2014), %

45%

Net income (2014)

$933.1 m

Market capitalization (21-Mar-2017)

$22.5 b

Closing share price (21-Mar-2017)

$42.2

Cash (31-May-2016)

£28.7 k
Mylan's current market capitalization is $22.5 b.
Mylan's revenue was reported to be $7.6 b in FY, 2014 which is a 11.5% increase from the previous period.
FY, 2013FY, 2014

Revenue

$6.9 b$7.6 b

Revenue growth, %

12%

Cost of goods sold

$3.9 b$4.2 b

Gross profit

$3 b$3.5 b

Gross profit Margin, %

44%45%

Operating expense total

$1.9 b$2.2 b

Interest expense

$313.3 m$333.2 m

Income tax expense

$120.8 m$41.4 m

Net Income

$626.5 m$933.1 m
FY, 2013FY, 2014FY, 2015FY, 2016

Cash

$291.3 m£28.9 k£15.3 k£28.7 k

Accounts Receivable

$1.8 b£9.3 k£20 k£12.7 k

Inventories

$1.7 b£1.7 b

Current Assets

$4.5 b£38.1 k£35.3 k£41.4 k

PP&E

$1.7 b£858.6 k£856.9 k£856.3 k

Goodwill

$4.3 b£210 k£189 k£189 k

Total Assets

$15.2 b£1.1 m£1.1 m£1.1 m

Accounts Payable

$1.1 b£656.6 k£592.6 k£639.3 k

Total Debt

$8 b£6.1 b

Current Liabilities

$3 b£656.6 k£592.6 k£639.3 k

Additional Paid-in Capital

$4.1 b£4.2 b

Retained Earnings

$2.7 b

Total Equity

$3 b£1.9 k£2.2 k£2.2 k

Debt to Equity Ratio

2.7 x3174607.3 x

Debt to Assets Ratio

0.5 x5478.9 x

Financial Leverage

5.1 x579.4 x492.8 x484.1 x
FY, 2013FY, 2014

Net Income

$626.5 m$933.1 m

Depreciation and Amortization

$516 m$566.6 m

Accounts Receivable

($550 m)($940 m)

Inventories

($160 m)($150 m)

Accounts Payable

$137.2 m($300 k)

Cash From Operating Activities

$1.1 b$1 b

Capital Expenditures

($334.6 m)($325.3 m)

Cash From Investing Activities

($1.9 b)($800.3 m)

Cash From Financing Activities

$692.9 m($267.4 m)

Interest Paid

$249.4 m$273.8 m

Income Taxes Paid

($1.1 m)$78.5 m

Free Cash Flow

$1.4 b$1.3 b

Mylan Market Value History

Mylan Median Salaries

Source: 123 public H-1B filings from Mylan

Mylan Online Presence

Mylan News

Mylan Company Life

You may also be interested in